Institut National du Cancer
France's national cancer agency, which steers the national cancer strategy and funds and labels research, trial networks and early-phase units.
Created by the 2004 public health law as the operational arm of the first Plan Cancer, INCa is a public interest group under the health and research ministries. It coordinates the ten-year national cancer strategy, funds research through calls such as PAIR and PHRC-K, labels the SIRIC integrated research sites and the CLIP² early-phase trial network, and ran the AcSé programme that gave patients access to targeted drugs outside their approved indication based on molecular profile. It publishes national guidelines, screening programmes and cancer statistics with Santé publique France.
- National cancer strategy
- SIRIC sites
- CLIP² early-phase network
- AcSé access programme
- Screening and guidelines
Pages like this
not linked directly; found by shared links- InstitutionFondation ARC pour la recherche sur le cancer
Shares Institut Curie, UNICANCER, Gustave Roussy, Funding follows fashion, not burden.
- IdeaOne standing umbrella trial for all rare cancers in a country
Shares UNICANCER, Tumour-agnostic (tissue-agnostic) approval, Basket, umbrella, and platform trials, Trials enrol too few, too slowly.
- PersonChristophe Le Tourneau
Shares Institut Curie, UNICANCER.
- InstitutionHaute Autorité de Santé
Shares Institut Curie, UNICANCER, Gustave Roussy.
- InstitutionLigue nationale contre le cancer
Shares UNICANCER, Gustave Roussy.
- CollectionPancreatic Cancer Action Network (PanCAN)
Shares Tumour-agnostic (tissue-agnostic) approval, Basket, umbrella, and platform trials.
- IdeaA dedicated global financing window for cancer, modelled on the Global Fund
Shares International Agency for Research on Cancer (IARC / WHO), Funding follows fashion, not burden.
- IdeaA global first-in-human network for academic cancer trials with single ethics review
Shares Gustave Roussy, Basket, umbrella, and platform trials, Trials enrol too few, too slowly.